US 11,964,095 B2
Condensate absorbing and dissipating system
Timothy Mark Robinson, Shillingstone (GB); and Christopher Brian Locke, Bournemouth (GB)
Assigned to Solventum Intellectual Properties Company, Maplewood, MN (US)
Filed by KCI Licensing, Inc., San Antonio, TX (US)
Filed on Sep. 21, 2021, as Appl. No. 17/480,930.
Application 17/480,930 is a continuation of application No. 16/151,005, filed on Oct. 3, 2018, granted, now 11,154,650.
Application 16/151,005 is a continuation of application No. 14/490,886, filed on Sep. 19, 2014, granted, now 10,398,814, issued on Sep. 3, 2019.
Claims priority of provisional application 61/897,651, filed on Oct. 30, 2013.
Prior Publication US 2022/0001099 A1, Jan. 6, 2022
Int. Cl. A61M 1/00 (2006.01); A61F 13/00 (2006.01); A61F 13/0203 (2024.01); A61F 13/05 (2024.01); A61F 13/15 (2006.01); A61F 13/537 (2006.01)
CPC A61M 1/90 (2021.05) [A61F 13/022 (2013.01); A61F 13/05 (2024.01); A61M 1/80 (2021.05); A61F 2013/00174 (2013.01); A61F 2013/0028 (2013.01); A61F 2013/00719 (2013.01); A61F 2013/15536 (2013.01); A61F 13/53717 (2013.01)] 17 Claims
OG exemplary drawing
 
1. A system for treating a tissue site, comprising:
a dressing, comprising:
a base layer adapted to cover the tissue site and tissue surrounding the tissue site,
a sealing member adapted to form an enclosure relative to the base layer, and
an absorbent layer disposed in the enclosure; and
a conduit adapted to be positioned in fluid communication between the dressing and a reduced-pressure source, wherein the conduit includes at least one lumen, a first portion of the conduit being comprised of a hydrophobic polymer and a second portion of the conduit being comprised of a hydrophilic polymer, at least a portion of an external surface of the conduit comprising the hydrophilic polymer.